Stocks & IPOs
IPOs: from an offering to an investment case
Connect IPO financing with a disciplined assessment of the business, offering terms, price and risk.
01An IPO is a financing event
Listing changes financing and disclosure, not the fundamental research questions. Understand customers, revenue, cash and resource needs before following market themes. Identify the issuer and actual equity interest, distinguishing the operating business, brand, affiliates and secondary sellers. Public visibility is not proof of mature economics or assured outcomes.
02Build an evidence chain
Use dated, versioned offering documents and disclosures. Connect business claims with financial results, risk statements and proposed funding uses. Check whether expansion plans fit orders and cash needs. Media and promotional material can suggest questions but should not be confused with independent verification.
03Explain growth quality
Decompose growth into customers, usage, pricing, products and acquisitions. Compare it with working capital and delivery spending. AI needs unit economics, data businesses need rights and collection, and energy businesses need capacity and connection analysis. Short histories require ranges and milestones, not confident long-term extrapolation.
04Understand rights and funding uses
Review control, incentives, pre-IPO investors and related parties without treating prestigious participation as a return guarantee. Connect proceeds with execution milestones and further financing needs. Use consistent post-offering share counts and consider potential dilution when evaluating per-share economics.
05Include unsuccessful paths
Peer comparisons need similar economics, not selected high multiples. Model slower customer growth, lower prices, delays and funding changes consistently. Use ranges for uncertain inputs. The objective is to reveal what the price requires and which deviations matter, not to manufacture precision.
06Preserve offering-stage boundaries
Subscription enthusiasm cannot assure future cash, allocation or listing performance. Financing involves interest, fees and cash occupation under the applicable documents. Research is not a personal suitability assessment or a substitute for regulated professional services. Waiting is a legitimate conclusion when evidence, price or conditions are unsuitable.
07Describe corporate context accurately
SilverCape's Hong Kong branch supports regional connections, but corporate presence is not universal authorisation. Registration, identity records and regulatory qualifications have different purposes. Any approval must be read within its actual scope and does not endorse an individual IPO's merits or returns. Company context cannot replace issuer analysis.
08Connect the offering with later evidence
For a hypothetical new-product programme, link customer need, development resources, pricing and support with proceeds, dilution and valuation timing. After listing, test the same milestones through paid adoption, costs and cash rather than replacing the thesis with a price-only narrative.
09Continue after listing
Review operating disclosures, capital use and governance against the original thesis. Track supporting, contrary and unresolved evidence with reasons for revisions. SilverCape treats IPO research as an ongoing study of companies and markets, extending well beyond offering momentum and first-day performance.
